Class I histone deacetylase inhibitors inhibit the retention of BRCA1 and 53BP1 at the site of DNA damage

Publisher: John Wiley & Sons Inc

E-ISSN: 1349-7006|106|8|1050-1056

ISSN: 1347-9032

Source: Cancer Science, Vol.106, Iss.8, 2015-08, pp. : 1050-1056

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract